Mert, A. Et Al. 2024. Multicenter evaluation of ceftazidime-avibactam use in carbapenem-resistant Klebsiella pneumoniae bloodstream infections in OXA-48 endemic regions.. Scientific reports , vol.14, no.1 , 26337.

Mert, A., Derin, O., Akalın, H., Dumlu, R., Gündeş, S., Zengin, R., ... Kocagöz, S.(2024). Multicenter evaluation of ceftazidime-avibactam use in carbapenem-resistant Klebsiella pneumoniae bloodstream infections in OXA-48 endemic regions.. Scientific reports , vol.14, no.1, 26337.

Mert, Ali Et Al. "Multicenter evaluation of ceftazidime-avibactam use in carbapenem-resistant Klebsiella pneumoniae bloodstream infections in OXA-48 endemic regions.," Scientific reports , vol.14, no.1, 26337, 2024

Mert, Ali Et Al. "Multicenter evaluation of ceftazidime-avibactam use in carbapenem-resistant Klebsiella pneumoniae bloodstream infections in OXA-48 endemic regions.." Scientific reports , vol.14, no.1, pp.26337, 2024

Mert, A. Et Al. (2024) . "Multicenter evaluation of ceftazidime-avibactam use in carbapenem-resistant Klebsiella pneumoniae bloodstream infections in OXA-48 endemic regions.." Scientific reports , vol.14, no.1, p.26337.

@article{article, author={Ali Mert Et Al. }, title={Multicenter evaluation of ceftazidime-avibactam use in carbapenem-resistant Klebsiella pneumoniae bloodstream infections in OXA-48 endemic regions.}, journal={Scientific reports}, year=2024, pages={26337} }